CD28null CD57+ CX3CR1+ T cells

1 paper studies it2 findings

Interventions

SARS-COV-2 infection

no changein humans1upin humans1

1 study

SARS-COV-2 infection has no effect on CD28null CD57+ CX3CR1+ T cells in humans.
“This expansion did not occur in CMV-seronegative mCOVID-19 individuals or in CMV-seropositive individuals infected after SARS-CoV-2 vaccination.”
Humansin CMV-seronegative individuals or CMV-seropositive individuals infected after SARS-CoV-2 vaccination
Accelerated T-Cell Immunosenescence in Cytomegalovirus-Seropositive Individuals After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The Journal of infectious diseasesApr 27, 2023
SARS-COV-2 infection increases CD28null CD57+ CX3CR1+ T cells in humans.
“A significant increase in CD28nullCD57+CX3CR1+ T cell percentages (CD4+ [P ≤ .01], CD8+ [P ≤ .01], and TcRγδ (CD4-CD8-) [P ≤ .001]) was found in unnvaccinated CMV-seropositive mCOVID-19 individuals”
Humansin unvaccinated CMV-seropositive individuals, stable up to 12 months after infection
Accelerated T-Cell Immunosenescence in Cytomegalovirus-Seropositive Individuals After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
The Journal of infectious diseasesApr 27, 2023

The Journal of Infectious DiseasesApr 27

Cohort study in peopleLung